Inherited predisposition of lung cancer: A hierarchical modeling approach to DNA repair and cell cycle control pathways

Cancer Epidemiology Biomarkers and Prevention

Volumn 16, Issue 12, 2007, Pages 2736-2744

  Hung, Rayjean J ^a,b   Baragatti, Meili ^a,c   Thomas, Duncan ^d   McKay, James ^a   Szeszenia Dabrowska, Neonila ^e   Zaridze, David ^f   Lissowska, Jolanta ^g   Rudnai, Peter ^h   Fabianova, Eleonora ⁱ   Mates, Dana ^j   Foretova, Lenka ^k   Janout, Vladimir ^l   Bencko, Vladimir ^m   Chabrier, Amelie ^a   Moullan, Norman ^a   Canzian, Federico ⁿ   Hall, Janet ^o   Boffetta, Paolo ^a   Brennan, Paul ^a  

^a INTERNATIONAL AGENCY FOR RESEARCH ON CANCER   (France)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c ENSAI Ecole Nationale de la Statistique et de lAnalyse de lInformation   (France)

^d UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

^e NOFER INSTITUTE OF OCCUPATIONAL MEDICINE   (Poland)

^f N N BLOKHIN RUSSIAN CANCER RESEARCH CENTER   (Russian Federation)

^g INSTITUTE OF ONCOLOGY   (Poland)

^h Jozsef Fodor National Center for Public Health   (Hungary)

ⁱ Specialized Institute of Hygiene and Epidemiology   (Slovakia)

^j NATIONAL INSTITUTE OF PUBLIC HEALTH   (Romania)

^k MASARYK MEMORIAL CANCER INSTITUTE   (Czech Republic)

^l PALACKÝ UNIVERSITY   (Czech Republic)

^m CHARLES UNIVERSITY   (Czech Republic)

ⁿ GERMAN CANCER RESEARCH CENTER DKFZ   (Germany)

^o INSERM U612   (France)

more..

Author keywords

[No Author keywords available]

Indexed keywords

BIOLOGICAL MARKER; CHECKPOINT KINASE 2; METHYLATED DNA PROTEIN CYSTEINE METHYLTRANSFERASE; POLYDEOXYRIBONUCLEOTIDE SYNTHASE;

ADULT; AGED; ARTICLE; BAYES THEOREM; CANCER PATIENT; CANCER RISK; CANCER SUSCEPTIBILITY; CELL CYCLE REGULATION; CONFIDENCE INTERVAL; CONTROLLED STUDY; DISEASE MARKER; DNA REPAIR; FEMALE; GENE SEQUENCE; GENETIC ASSOCIATION; GENETIC LINKAGE; GENETIC SUSCEPTIBILITY; GENETIC VARIABILITY; HAPLOTYPE; HOMOZYGOSITY; HUMAN; HYPOTHESIS; INHERITANCE; LUNG CANCER; MAJOR CLINICAL STUDY; MALE; MATHEMATICAL MODEL; PHYSICAL CHEMISTRY; PRIORITY JOURNAL; RISK ASSESSMENT;

EID: 38849197454     PISSN: 10559965     EISSN: None     Source Type: Journal    
DOI: 10.1158/1055-9965.EPI-07-0494     Document Type: Article

References (35)

1. Goldgar DE, Easton DF, Cannon-Albright LA, Skolnick MH. Systematic population-based assessment of cancer risk in first-degree relatives of cancer probands. J Natl Cancer Inst 1994;86:1600-8.
2. Amundadottir LT, Thorvaldsson S, Gudbjartsson DF, et al. Cancer as a complex phenotype: pattern of cancer distribution within and beyond the nuclear family. PLoS Med 2004;1:e65.
3. Hemminki K, Czene K. Attributable risks of familial cancer from the Family-Cancer Database. Cancer Epidemiol Biomarkers Prev 2002;11:1638-44.
4. Matakidou A, Eisen T, Houlston RS. Systematic review of the relationship between family history and lung cancer risk. Br J Cancer 2005;93:825-33.
5. Bailey-Wilson JE, Amos CI, Pinney SM, et al. A major lung cancer susceptibility locus maps to chromosome 6q23-25. Am J Hum Genet 2004;75:460-74.
6. Hoeijmakers JH. Genome maintenance mechanisms for preventing cancer. Nature 2001;411:366-74.
7. Mohrenweiser HW, Jones IM. Variation in DNA repair is a factor in cancer susceptibility: a paradigm for the promises and perils of individual and population risk estimation? Mutat Res 1998;400:15-24.
8. Kastan MB, Bartek J. Cell-cycle checkpoints and cancer. Nature 2004;432:316-23.
9. Landi S, Gemignani F, Canzian F, et al. DNA repair and cell cycle control genes and the risk of young onset lung cancer. Carcinogenesis. In press 2006.
10. Ware MD, DeSilva D, Sinilnikova OM, Stoppa Lyonnet D, Tavtigian SV, Mazoyer S. Does nonsense-mediated mRNA decay explain the ovarian cancer cluster region of the BRCA2 gene? Oncogene 2006;25:323-8.
11. Ng PC, Henikoff S. Accounting for human polymorphisms predicted to affect protein function. Genome Res 2002;12:436-46.
12. Hung RJ, Brennan P, Canzian F, et al. Large-scale investigation of base excision repair genetic polymorphisms and lung cancer risk in a multicenter study. J Natl Cancer Inst 2005;97:567-76.
13. Hung RJ, Boffetta P, Canzian F, et al. Sequence variants in cell cycle control pathway, x-ray exposure, and lung cancer risk: a multicenter case-control study in Central Europe. Cancer Res 2006;66:8280-6.
14. Brennan P, McKay J, Moore L, et al. Uncommon CHEK2 mis-sense variant and reduced risk of tobacco-related cancers: case control study. Hum Mol Genet 2007;16:1794-801.
15. Stram DO. Software for tag single nucleotide polymorphism selection. Hum Genomics 2005;2:144-51.
16. Hung RJ, Brennan P, Malaveille C, et al. Using hierarchical modeling in genetic association studies with multiple markers: application to a case-control study of bladder cancer. Cancer Epidemiol Biomarkers Prev 2004;13:1013-21.
17. Ng PC, Henikoff S. Predicting deleterious amino acid substitutions. Genome Res 2001;11:863-74.
18. Witte JS, Greenland S, Kim LL. Software for hierarchical modeling of epidemiologic data. Epidemiology 1998;9:563-6.
19. Ishikawa T, Ide F, Qin X, et al. Importance of DNA repair in carcinogenesis: evidence from transgenic and gene targeting studies. Mutat Res 2001;477:41 - 9.
20. Pegg AE, Dolan ME, Moschel RC. Structure, function, and inhibition of O6-alkylguanine-DNA alkyltransferase. Prog Nucleic Acid Res Mol Biol 1995;51:167-223.
21. 6-alkylguanine-DNA alkyltransferase are expressed at different levels in normal human lung tissue. Carcinogenesis 2003;24:1691-4.
22. 6- alkylguanine DNA alkyltransferase gene in lung cancer risk. Cancer Epidemiol Biomarkers Prev 2000;9:339-42.
23. 6-alkylguanine DNA alkyltransferase gene and lung cancer risk in non-smokers exposed to second-hand smoke. Cancer Epidemiol Biomarkers Prev 2004;13:320-3.
24. 6- methylguanine-DNA methyltransferase-codon 178 genetic polymorphism. Lung Cancer 2004;44:281-6.
25. Krzesniak M, Butkiewicz D, Samojedny A, Chorazy M, Rusin M. Polymorphisms in TDG and MGMT genes - epidemiological and functional study in lung cancer patients from Poland. Ann Hum Genet 2004;68:300-12.
26. Zienolddiny S, Campa D, Lind H, et al. Polymorphisms of DNA repair genes and risk of non-small cell lung cancer. Carcinogenesis 2005;27:260-7.
27. 6-alkylguanine-DNA alkyltransferase gene polymorphisms and the risk of primary lung cancer. Mol Carcinog 2006;45:239-49.
28. 6-methylguanine-DNA methyltransferase. Biochemistry 1997;36:5769-76.
29. Ford BN, Ruttan CC, Kyle VL, Brackley ME, Glickman BW. Identification of single nucleotide polymorphisms in human DNA repair genes. Carcinogenesis 2000;21:1977-81.
30. Brennan P, McKay J, Moore L, et al. An uncommon CHEK2 polymorphism and the risk of lung and UADT cancer. Human Molecular Genetics 2007;16:1794-801.
31. Rafii S, O'Regan P, Xinarianos G, et al. A potential role for the XRCC2 R188H polymorphic site in DNA-damage repair and breast cancer. Hum Mol Genet 2002;11:1433-8.
32. Matullo G, Dunning AM, Guarrera S, et al. DNA repair polymorphisms and cancer risk in non-smokers in a cohort study. Carcinogenesis 2006;27:997-1007.
33. Rudd MF, Webb EL, Matakidou A, et al. Variants in the GH-IGF axis confer susceptibility to lung cancer. Genome Res 2006;16:693-701.
34. Greenland S. Principles of multilevel modelling. Int J Epidemiol 2000;29:158-67.
35. Greenland S, Poole C. Empirical-Bayes and semi-Bayes approaches to occupational and environmental hazard surveillance. Arch Environ Health 1994;49:9-16.